Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The University of Texas MD Anderson Cancer Center is renamed to M.D. Anderson Cancer Center in the locations list, and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T23:30:06.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now includes a glossary display option, a new 'Last Update Submitted that Met QC Criteria' label, and a revision indicator (Revision: v3.4.0), while previous wording variants for QC status and FEAR Act data were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:45:51.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page shows a technical revision update from v3.3.3 to v3.3.4 without changes to study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:05:10.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Locations were added and state-specific location sections were reorganized; the page now presents trial sites by state (CA, DC, FL, MI, MN, MO, NY, NC, OR, PA) under Locations. The HHS Vulnerability Disclosure link was removed and the revision label updated from v3.3.2 to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T20:56:29.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Publications section now states that PubMed-derived publications are automatically filled and may not be about the study. The page revision label updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:12:34.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Removed a government funding status notice that previously informed users about potential delays and operating status; the study page content and eligibility information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T03:27:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.